Current Pharmaceutical Design
Title: Editorial [ Adhesion Molecules and Drug Targeting Executive Editor: Seetharama D.S. Jois ]
Volume: 12 Issue: 22
Author(s): Seetharama D.S. Jois
Affiliation:
Export Options
About this article
Cite this article as:
Jois D.S. Seetharama, Editorial [ Adhesion Molecules and Drug Targeting Executive Editor: Seetharama D.S. Jois ], Current Pharmaceutical Design 2006; 12 (22) . https://dx.doi.org/10.2174/138161206777947687
DOI https://dx.doi.org/10.2174/138161206777947687 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
13
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
(Phospho)lipid-based Nanosystems for Skin Administration
Current Pharmaceutical Design Impact of Curcumin on Traumatic Brain Injury and Involved Molecular Signaling Pathways
Recent Patents on Food, Nutrition & Agriculture Innate Immunity in the Pathogenesis of Cholangiopathy: A Recent Update
Inflammation & Allergy - Drug Targets (Discontinued) Delineating Somatostatins Neuronal Actions
Current Drug Targets - CNS & Neurological Disorders Arginyl Aminopeptidase-Like 1 (RNPEPL1) Is an Alternatively Processed Aminopeptidase with Specificity for Methionine, Glutamine, and Citrulline Residues
Protein & Peptide Letters Proanthocyanidins in Health Care: Current and New Trends
Current Medicinal Chemistry Targeting Toll-Like Receptor Signaling Pathways for Design of Novel Immune Therapeutics
Current Drug Discovery Technologies HIV-1 Vpu Interference with Innate Cell-mediated Immune Mechanisms
Current HIV Research Potential Options to Treat Hypertriglyceridaemia
Current Drug Targets Cationic Antimicrobial Peptides for Tuberculosis: A Mini-Review
Current Protein & Peptide Science Structural Characterization of Carbohydrates by Fourier Transform Tandem Mass Spectrometry
Current Proteomics Modulatory Factors Responsible for Neoangiogenesis in Young Patients with Long-Standing Diabetes Mellitus Type 1
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Evaluation of Topical Black Seed Oil in the Treatment of Allergic Rhinitis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Role of Fas-Ligand Induced Apoptosis in Pulmonary Inflammation and Injury
Current Drug Targets - Inflammation & Allergy Editorial [Hot Topic: Protein Kinase Inhibitors: Current Strategies and Future Prospects (Executive Guest Editor: Julio Caballero)]
Current Pharmaceutical Design Midkine: A Promising Molecule for Drug Development to Treat Diseases of the Central Nervous System
Current Pharmaceutical Design B-Cell Based Gene Therapy for Autoimmune Diseases
Infectious Disorders - Drug Targets Sesamol Ameliorates Cyclophosphamide-Induced Hepatotoxicity by Modulating Oxidative Stress and Inflammatory Mediators
Anti-Cancer Agents in Medicinal Chemistry Bile Acids and Derivatives, Their Nuclear Receptors FXR, PXR and Ligands: Role in Health and Disease and Their Therapeutic Potential
Anti-Cancer Agents in Medicinal Chemistry Epigenetics in Multiple Sclerosis: Molecular Mechanisms and Dietary Intervention
Central Nervous System Agents in Medicinal Chemistry